Document is current
Any future updates will be listed below
-
Authors
Jadhav, Prakash
Liang, Xueying
Ansari, Ahmadullah https://orcid.org/0000-0003-3398-175X
Tan, Bin https://orcid.org/0000-0001-6295-6962
Tan, Haozhou
Li, Kan https://orcid.org/0000-0002-0825-1934
Chi, Xiang https://orcid.org/0009-0003-4853-7931
Ford, Alexandra https://orcid.org/0000-0001-8531-1243
Ruiz, Francesc Xavier https://orcid.org/0000-0002-0457-0030
Arnold, Eddy
Deng, Xufang
Wang, Jun https://orcid.org/0000-0002-4845-4621
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI158775, U19AI171110, AI158775)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (U01HL150852)
- License Information
-
More Information
Article History
Received: 19 September 2024
Accepted: 29 January 2025
First Online: 13 February 2025
Competing interests
: Rutgers, the State University of New Jersey, has applied for a patent US2024382494A1 covering the PLpro inhibitors reported in this study and related compounds, which has been published and is pending. J.W. is listed as an inventor. The remaining authors declare no competing interests.
